Anne-Catherine Berner Appointed as New Chair of Grifols: A Strategic Move Toward Long-Term Value Creation and Governance Excellence Grifols a global leader in the development of plasma-derived therapies and diagnostic technologies, has announced a key leadership transition following its 2025…
Bayer’s CONFIDENCE Study Demonstrates Promising Results for Simultaneous Use of Finerenone and Empagliflozin in Managing Chronic Kidney Disease in Type 2 Diabetes Bayer has announced compelling new clinical findings from its Phase II CONFIDENCE trial, which evaluated the simultaneous initiation…
Zoetis Unveils 2024 Sustainability Progress Report, Showcasing Global Commitments to Communities, Animal Health, and the Planet Zoetis, a global leader in animal health, has released its 2024 Sustainability Progress Update, titled “Advancing Sustainability in Animal Health for a Better Future,”…
Sanofi Unveils 2025 Global Employee Shareholding Plan, Reinforcing Long-Term Workforce Commitment Sanofi has officially launched Action 2025, the latest installment of its long-running global employee shareholder program. Opening on June 10, 2025, the initiative offers approximately 70,000 eligible employees across…
Vividion and Bayer Expand Oncology Pipeline with Exclusive Rights to Clinical-Stage WRN Inhibitor VVD-214 Vividion Therapeutics,a clinical-stage biopharmaceutical company and wholly owned subsidiary of Bayer AG, has announced a significant expansion of its oncology development pipeline through the acquisition of…
CPR Training Turns Walgreens Manager into a Hero Dad: How Quick Thinking Saved His Daughter’s Life Adyn Romahn was enjoying a quiet moment at home in Great Bend, Kansas, watching television while his two-year-old daughter, Emmy, played contentedly on the…
Neglected Again: ODA Cuts Threaten Global Progress on Tropical Diseases Neglected tropical diseases (NTDs) continue to plague over a billion people around the world, predominantly affecting vulnerable populations in low-resource settings across Africa, Asia, and Latin America. These diseases —…
Global Drive for Primary Health Care Gains Ground at World Health Assembly: A Unified Call to Action In a powerful demonstration of international unity and purpose, global health leaders convened at a pivotal side event during the Seventy-eighth World Health…
Legend Biotech Unveils Landmark Five-Year Survival Data for CARVYKTI® in Relapsed/Refractory Multiple Myeloma at ASCO 2025 Legend Biotech Corporation,a global leader in cell therapy innovation, presented groundbreaking long-term data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting,…
Takeda Secures European Commission Approval for ADCETRIS® in Combination with ECADD as a New Frontline Therapy for Adults with Advanced-Stage Hodgkin Lymphoma Takeda has announced a major milestone in the treatment landscape for Hodgkin lymphoma with the European Commission’s (EC)…
ASCO 2025: Subcutaneous Sarclisa with On-Body Injector Shows Promise in Multiple Myeloma Treatment At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Sanofi presented promising data from two pivotal clinical trials evaluating the investigational subcutaneous (SC) delivery of…
AbbVie Launches Second Annual Migraine Career Catalyst Award to Empower People with Migraine in Pursuit of Their Professional Dreams Pharmaceutical company AbbVie has announced the return of its AbbVie Migraine Career Catalyst Award™, a unique initiative designed to support individuals…
